TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.29M | -27.76M | -23.50M | -21.68M | -18.37M |
| Total Depreciation and Amortization | 66.40K | 74.20K | 96.40K | 116.60K | 135.00K |
| Total Amortization of Deferred Charges | 171.40K | 840.20K | 1.26M | 1.28M | 1.11M |
| Total Other Non-Cash Items | 5.86M | 4.16M | 3.37M | 2.27M | 1.30M |
| Change in Net Operating Assets | -1.48M | 5.88M | 3.14M | 3.29M | 660.60K |
| Cash from Operations | -24.67M | -16.81M | -15.63M | -14.73M | -15.16M |
| Capital Expenditure | -69.70K | -69.70K | -100.60K | -57.90K | -76.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -7.25M | -12.45M | -12.30M | -11.19M | -5.19M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.19M | 5.19M | 5.19M | 5.19M | -- |
| Cash from Investing | -2.13M | -7.32M | -7.20M | -6.05M | -5.27M |
| Total Debt Issued | 0.00 | 9.50M | 23.67M | 28.57M | 31.25M |
| Total Debt Repaid | -1.37M | -796.90K | -796.90K | -796.90K | -- |
| Issuance of Common Stock | 15.75M | 16.58M | 7.55M | 7.05M | 7.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -6.30K | -4.20K | -2.10K | -- | -- |
| Other Financing Activities | -4.46M | -4.94M | -5.82M | -5.05M | -2.31M |
| Cash from Financing | 9.91M | 20.34M | 24.59M | 29.77M | 35.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.90M | -3.80M | 1.76M | 8.99M | 15.55M |